Viking Global Investors Lp

13F Holdings History for BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO)

Symbol: BBIO on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 15.9M shares
Security Ownership: 8.2%

Shares, Excluding Options vs Price

Value, Excluding Options

VIKING GLOBAL INVESTORS LP ownership in BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO)

2025-11-14 - VIKING GLOBAL INVESTORS LP has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 15.9M shares of BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO). This represents 8.2% percent ownership of the company. In their previous filing dated 2025-08-14, VIKING GLOBAL INVESTORS LP had reported owning 18.6M shares, indicating a decrease of -14.6% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
VIKING GLOBAL INVESTORS LP	8.2%	-15%	$826M	15.9M	-2,708,986	-14.6%	$51.94	13D/A	11/14/2025	14 Nov 2025 16:52:32
HALVORSEN OLE ANDREAS	9.7%	-1%	$978M	18.6M			$52.57	13D/A	8/14/2025	14 Aug 2025 20:32:31
VIKING GLOBAL INVESTORS LP	9.8%	-15.8%	$648M	18.6M	-3,452,455	-15.7%	$34.85	13D/A	6/27/2025	1 Jul 2025 19:49:36
VIKING GLOBAL INVESTORS LP	11.7%		$725M	22.1M			$32.88	13D/A	1/31/2025	12 Mar 2025 16:28:02
VIKING GLOBAL INVESTORS LP	11.7%		$725M	22.1M			$32.88	13D/A	1/31/2025	31 Jan 2025 19:18:50

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	2.16%	-0.35%	$830M	16M	-2,577,526	-13.9%	$51.94	Q3 2025
6/30/2025	2.32%	-0.44%	$801M	18.6M	-3,500,000	-15.9%	$43.18	Q2 2025
3/31/2025	2.42%	-0.34%	$762M	22.1M	-3,065,616		$34.57	Q1 2025
12/31/2024	2.23%		$689M	25.1M			$27.44	Q4 2024
9/30/2024	2.33%		$640M	25.1M			$25.46	Q3 2024
6/30/2024	2.45%		$636M	25.1M			$25.33	Q2 2024
3/31/2024	2.89%		$777M	25.1M			$30.92	Q1 2024
12/31/2023	3.71%		$1.01B	25.1M			$40.37	Q4 2023
9/30/2023	2.69%	-0.16%	$662M	25.1M	-1,500,000	-5.63%	$26.37	Q3 2023
6/30/2023	1.87%		$458M	26.6M			$17.20	Q2 2023
3/31/2023	2.07%		$441M	26.6M			$16.58	Q1 2023
12/31/2022	1.02%		$203M	26.6M			$7.62	Q4 2022
9/30/2022	1.22%		$265M	26.6M			$9.94	Q3 2022
6/30/2022	1.11%		$242M	26.6M			$9.08	Q2 2022
3/31/2022	1.09%		$270M	26.6M			$10.15	Q1 2022
12/31/2021	1.28%		$444M	26.6M			$16.68	Q4 2021
9/30/2021	3.42%		$1.25B	26.6M			$46.87	Q3 2021
6/30/2021	4.92%		$1.62B	26.6M			$60.96	Q2 2021
3/31/2021	4.88%		$1.64B	26.6M			$61.60	Q1 2021
12/31/2020	5.21%		$1.89B	26.6M			$71.11	Q4 2020
9/30/2020	3.61%		$999M	26.6M			$37.52	Q3 2020
6/30/2020	3.75%		$868M	26.6M			$32.61	Q2 2020
3/31/2020	4.02%		$772M	26.6M			$29.00	Q1 2020
12/31/2019	4.37%		$933M	26.6M			$35.05	Q4 2019
9/30/2019	2.98%		$572M	26.6M			$21.47	Q3 2019
6/30/2019	3.22%	+3.22%	$718M	26.6M	+26,620,991	NEW	$26.97	Q2 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.